Meeting
2023 ASCO Gastrointestinal Cancers Symposium
Plasma central carbon metabolite changes associated with KRAS mutation and circulating tumor DNA (ctDNA) status in colorectal cancer (CRC).
Authors
Daniel Myung Kim
Cedars-Sinai Medical Center, Los Angeles, CA;
Daniel Myung Kim , Francesca Paola Aguirre , Alexandra Gangi , Rocio Alvarez , Lisa Zhou , Johanna ten Hoeve , Yi Jou Liao , Thomas Graeber , Andrew Eugene Hendifar , Arsen Osipov , Kamya Sankar , May Thet Cho , Anser Abbas , John Davelaar , Megan Philippa Hitchins , Jun Gong
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Cancers of the Colon, Rectum, and Anus
Track
Colorectal Cancer,Anal Cancer
Sub Track
Translational Research
Citation
J Clin Oncol 41, 2023 (suppl 4; abstr 181)
DOI
10.1200/JCO.2023.41.4_suppl.181
Abstract #
181
Poster Bd #
K3
Abstract Disclosures
Similar Posters
Poster
2014 ASCO Annual Meeting
Prognostic and predictive blood-based biomarkers of overall survival (OS) in patients (pts) with advanced colorectal cancer (CRC) treated with cetuximab (C): Results from CALGB 80203 (Alliance).
First Author: Ace Joseph Hatch
Poster
2014 Gastrointestinal Cancers Symposium
Prognostic and predictive blood-based biomarkers of overall survival (OS) in patients (pts) with advanced colorectal cancer (CRC) treated with cetuximab (C): Results from CALGB 80203 (Alliance).
First Author: Ace J. Hatch
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Association of candidate alterations with primary resistance to KRAS G12D targeting in colorectal cancer.
First Author: Khalid Jazieh
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Circulating tumor DNA–based genomic landscape of KRAS wild-type pancreatic adenocarcinoma.
First Author: Brendon Fusco